Colospa (Mebeverine)

Colospa (Mebeverine) – Patient Information Leaflet

Basic Product Information

Mechanism of Action

For Patients: Colospa (Mebeverine) is a medicine that acts directly on the smooth muscles of your gut (intestines and colon). It helps to relax these muscles, thereby relieving abdominal pain and cramps, bloating, and discomfort associated with conditions such as irritable bowel syndrome (IBS).

For Specialists: Mebeverine is a musculotropic antispasmodic agent that inhibits abnormal muscular contractions without affecting normal gut motility or causing significant anticholinergic side effects. It is believed to work by reducing calcium influx into smooth muscle cells and modulating sodium and potassium channels within the GI tract.

Pharmacokinetics

• Absorption: Mebeverine is rapidly and well absorbed after oral administration. The modified-release forms ensure prolonged action.
• Metabolism: Undergoes extensive first-pass metabolism in the liver, mainly into veratric acid derivatives, with no significant accumulation in tissues.
• Elimination: Mainly excreted via urine as metabolites.
• Duration of Action: Immediate-release tablets: effects last 4–6 hours; sustained-release capsules: effects last up to 12 hours.

Use in Everyday Life and Best Practices

Colospa is most often used for:

• Relieving abdominal pain, cramps, or discomfort caused by irritable bowel syndrome (IBS)
• Managing similar symptoms in other spastic bowel conditions such as spastic colitis or spastic constipation

Dosage and How to Use:
Adults typically take one 135 mg tablet three times daily, or one 200 mg modified-release capsule twice daily (morning and evening). The dose may be adjusted by your doctor based on your response and symptoms. Tablets and capsules should be swallowed whole with water; do not crush or chew.

Treatment should be continued regularly, especially when symptoms flare. You should consult your doctor before discontinuing, as abrupt cessation may result in recurrence of symptoms.

Dosing in the Morning vs Evening

• Morning Dosing: Ensures control of symptoms during daily activities, work, or study. Morning dose is especially important for those with day-predominant bloating or pain.
• Evening Dosing: Maintains relief overnight and into the next day. Particularly helpful for those who experience symptoms in the evening or at night.

Tip: Try to take your medicine at the same times each day to maintain steady symptom control. This makes it easier to remember and establishes a routine.

Taking Colospa With or Without Food

Colospa may be taken 20 minutes before meals for maximum effect, especially if symptoms are associated with eating. Some patients in Australia find that taking it on an empty stomach helps reduce mealtime-triggered discomfort. However, the modified-release capsules can be taken with or without food, according to individual tolerance and GI comfort.
Australian diet tip: There is no special need to change your diet unless advised by your doctor. However, maintaining regular meal times and staying hydrated may support better digestive comfort.

Interaction Warnings

Indications

Dosing According to Clinical Indications

Always follow your doctor’s dosage instructions, as individual needs may vary.

Safety Profile and Side Effects

• Common (may affect more than 1 in 100 people):
  • Mild gastrointestinal disturbances (nausea, constipation, diarrhoea, dyspepsia)
  • Headache
  • Dizziness
• Uncommon/Rare:
  • Hypersensitivity reactions (rash, hives, angioedema, anaphylaxis – very rare)
  • Bradycardia
  • Fatigue

Warnings: If you experience facial swelling, difficulty breathing, severe rash, or collapse—stop taking Colospa and seek urgent medical attention. Report prolonged or severe new abdominal pain, unexplained weight loss, blood in stools, or fever to your GP.

Guidelines for Proper Use (Australia-Specific Advice)

• Use Colospa only as prescribed by your GP or specialist.
• Keep the medicine in its original packaging in a cool, dry place below 30˚C, away from direct sunlight and out of reach of children.
• Do not share your medication, even if others have similar symptoms.
• Monitor your symptoms and discuss any persistent issues with your doctor, especially if you have other gut conditions, are pregnant, or breastfeeding.
• If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed one—do not double up doses.

Alternative Treatment Options

• Hyoscine butylbromide (Buscopan®): More suitable for acute colicky pain, often less prolonged effect, may cause more anticholinergic side effects (dry mouth, blurred vision).
• Peppermint oil: Herbal antispasmodic, mild to moderate symptoms, safe short-term but may cause reflux in some patients.
• Amitriptyline (low dose): Mainly for severe IBS with pain and associated mood issues, but has more side effects and requires regular supervision.
• Linaclotide, Lubiprostone: Used for IBS-C (constipation-predominant IBS) but require prescription and can cause diarrhoea.
• Loperamide: Used for diarrhoea-predominant IBS.

Most of these options require discussion with your treating doctor to determine the best fit based on your condition, comorbidities, and any other medications you are taking.

Legal, Registration, and Reimbursement Status in Australia

• Therapeutic Goods Administration (TGA): Colospa (mebeverine) is TGA approved for use in Australia for the treatment of symptoms of IBS and spastic colitis.
• Prescription Status: Schedule 4 (Prescription only).
• Pharmaceutical Benefits Scheme (PBS): Not routinely reimbursed for all indications; patients may need to pay the private prescription price.
• Legal Importation: Restricted to personal use in limited quantity (by TGA guidelines); not allowed to share or sell.

Latest Research and Clinical Guidance (2022–2025)

According to the most recent guidelines by the Australian Therapeutic Guidelines and the National Institute for Health and Care Excellence (NICE, UK), mebeverine remains a recommended first-line therapy for persistent abdominal pain and cramps in IBS, particularly when non-pharmacological measures (dietary adjustments, stress management, physical activity) are insufficient. A 2023 systematic review in the journal Gut affirms its safety profile and supports symptomatic improvement in IBS over placebo.
No significant new contraindications or safety warnings have emerged in recent years, and it continues to be widely prescribed in general and specialist practice.

Availability, Pack Sizes, and Delivery

• Common pack sizes: 30, 50 or 100 tablets/capsules per box
• Average private prescription price: $15–$25 per 30-tablet/capsule pack (as of 2024)

• Home delivery, collection services, and online pharmacy ordering are available nationwide. Always use a TGA-registered supplier or pharmacy.

Frequently Asked Questions (FAQ)

1. How quickly does Colospa start to work?
   Some people notice symptom relief within a few hours of the first dose, but full benefit is seen after several days of regular use. Consistency is key.
2. Can I drink alcohol while taking Colospa?
   Light to moderate alcohol does not directly interact with Colospa, but alcohol itself may worsen IBS symptoms. It’s best to be mindful and limit alcohol according to your body's response.
3. Is Colospa safe in pregnancy or breastfeeding?
   Animal studies show no direct harm, but Colospa is not routinely recommended during pregnancy or breastfeeding unless clearly needed and advised by your doctor. Always discuss with your GP or obstetrician first.
4. Can children use Colospa?
   Mebeverine is not routinely recommended for children under 10 years. Older children and teenagers should only take the medicine with a paediatrician’s supervision.
5. What should I do if I miss a dose?
   Take it as soon as you remember, unless it’s almost time for the next dose. Do not take a double dose to make up for the missed one.

Always consult your healthcare professional for personalised advice and before starting, stopping, or changing any medication regimen.